Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...
Hosted on MSN
Meet the Addyi pill, a.k.a. pink Viagra: Why the FDA's new 2025 approval is a ‘historic first' for women over 50
Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally entering the long-overdue conversation. The FDA recently approved the use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results